Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis.

JAMA psychiatry·2026
Same author

Implementation of biologic treatments for pyoderma gangrenosum through a service development framework.

Clinical and experimental dermatology·2026
Same author

Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
Same author

"I think there is a certain worm that disturbs the head": Community perspectives and care pathways for psychosis in Malawi.

PLOS mental health·2026
Same author

Understanding the long-term neurological effects of SARS-CoV-2 infection.

Nature reviews. Neurology·2026
Same author

Hidden immune memory niches in inflammatory skin diseases.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: May 19, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a

Bayanne Olabi1, Ian Ellison-Wright, Ed Bullmore

  • 1Division of Psychiatry, School of Molecular and Clinical Medicine, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, EH10 5HF, UK. b.olabi@sms.ed.ac.uk

BMC Psychiatry
|August 9, 2012
PubMed
Summary

First Episode Schizophrenia (FES) and Fronto-Temporal Lobar Degeneration (FTLD) show significant overlap in gray matter brain changes. Common affected areas include the bilateral caudate, left insula, and bilateral uncus, suggesting shared vulnerabilities.

More Related Videos

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
12:30

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures

Published on: July 2, 2014

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Related Experiment Videos

Last Updated: May 19, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures
12:30

A Comprehensive Protocol for Manual Segmentation of the Medial Temporal Lobe Structures

Published on: July 2, 2014

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

Area of Science:

  • Neuroimaging
  • Neuropsychiatry
  • Radiology

Background:

  • First Episode Schizophrenia (FES) and Fronto-Temporal Lobar Degeneration (FTLD) are distinct neurological disorders.
  • Understanding shared neurobiological underpinnings is crucial for diagnosis and treatment.

Purpose of the Study:

  • To compare gray matter changes in FES and FTLD using meta-analytic neuroimaging methods.
  • To identify the extent and spatial overlap of brain alterations in both conditions.

Main Methods:

  • Systematic search of structural MRI studies using voxel-based morphometry.
  • Anatomical Likelihood Estimation (ALE) meta-analysis to identify gray matter decreases.
  • Analysis of spatial overlap in brain changes between FES and FTLD.

Main Results:

  • Included 18 FES studies (555 patients) and 20 FTLD studies (311 patients).
  • Significant spatial overlap (p=0.001) in brain changes was observed between FES and FTLD.
  • Common gray matter deficits identified in bilateral caudate, left insula, and bilateral uncus.

Conclusions:

  • FES and FTLD exhibit significant overlap in structural brain changes.
  • This overlap may indicate shared etiological factors or common regional vulnerability.
  • Findings highlight potential common pathways in the pathogenesis of these disorders.